World Health Organization reference values for human semen characteristics

Human Reproduction Update

Volumn 16, Issue 3, 2009, Pages 231-245

  Cooper, Trevor G ^a   Noonan, Elizabeth ^b   von Eckardstein, Sigrid ^c   Auger, Jacques ^d   Baker, H W Gordon ^e   Behre, Hermann M ^f   Haugen, Trine B ^g   Kruger, Thinus ^h   Wang, Christina ⁱ   Mbizvo, Michael T ^c   Vogelsong, Kirsten M ^c  

^a INST OF REPRO MED OF THE UNIV   (Germany)

^b Fred Hutchinson Cancer Research Center   (United States)

^c WORLD BANK   (United States)

^d Service d'Histologie Embryologie   (France)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^g OSLO METROPOLITAN UNIVERSITY   (Norway)

^h STELLENBOSCH UNIVERSITY   (South Africa)

ⁱ LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Fertile men; Human semen; Infertility diagnosis; Reference values

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; EJACULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; MORPHOLOGY; POPULATION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY CONTROL; REFERENCE VALUE; RETROSPECTIVE STUDY; SEMEN ANALYSIS; SPERMATOZOON DENSITY; WORLD HEALTH ORGANIZATION; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; FATHER; MALE INFERTILITY; META ANALYSIS; METHODOLOGY; MIDDLE AGED; REVIEW; SPERM; STATISTICS;

ADOLESCENT; ADULT; AGED; FATHERS; HUMANS; INFERTILITY, MALE; MALE; MIDDLE AGED; REFERENCE VALUES; SEMEN; SEMEN ANALYSIS; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 77954485536     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmp048     Document Type: Article

References (122)

1. Andersen AG, Jørgensen N, Andersson AM, Carlsen E, Skakkebaek NE, Jensen TK, Keiding N, Swan SH. Serum levels of testosterone do not provide evidence of selection bias in studies of male reproductive health. Epidemiology 2000;11:232-234.
2. Andersen AG, Ziebe S, Jørgensen N, Petersen JH, Skakkebaek NE, Andersen AN. Time to pregnancy in relation to semen quality assessed by CASA before and after sperm separation. Hum Reprod 2002;17:173-177.
3. Andolz P, Bielsa MA, Vila J. Evolution of semen quality in North-eastern Spain: a study in 22,759 infertile men over a 36 year period. Hum Reprod 1999;14:731-735.
4. Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 1995;332:281-285.
5. Auger J, Eustache F, Andersen AG, Irvine DS, Jørgensen N, Skakkebaek NE, Suominen J, Toppari J, Vierula M, Jouannet P. Sperm morphological defects related to environment, lifestyle and medical history of 1001 male partners of pregnant women from four European cities. Hum Reprod 2001;16:2710-2717.
6. Barratt CL, Dunphy BC, Thomas EJ, Cooke ID. Semen characteristics of 49 fertile males. Andrologia 1988;20:264-269.
7. Barratt CL, Naeeni M, Clements S, Cooke ID. Clinical value of sperm morphology for in-vivo fertility: comparison between World Health Organization criteria of 1987 and 1992. Hum Reprod 1995; 10:587-593.
8. Bartoov B, Eltes F, Pansky M, Lederman H, Caspi E, Soffer Y. Estimating fertility potential via semen analysis data. Hum Reprod 1993;8:65-70.
9. Berling S, Wolner-Hanssen P. No evidence of deteriorating semen quality among men in infertile relationships during the last decade: a study of males from Southern Sweden. Hum Reprod 1997;12:1002-1005.
10. Berman NG, Wang C, Paulsen CA. Methodological issues in the analysis of human sperm concentration data. J Androl 1996;17:68-73.
11. Bonde JP, Ernst E, Jensen TK, Hjollund NH, Kolstad H, Henriksen TB, Scheike T, Giwercman A, Olsen J, Skakkebaek NE. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 1998;352:1172-1177.
12. Bostofte E, Serup J, Rebbe H. Has the fertility of Danish men declined through the years in terms of semen quality? A comparison of semen qualities between 1952 and 1972. Int J Fertil 1983;28:91-95.
13. Brady BM, Walton M, Hollow N, Kicman AT, Baird DT, Anderson RA. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception. Hum Reprod 2004; 11:2658-2667.
14. Brady BM, Amory J, Perheentupa A, Zitzmann M, Hay C, Apter D, Anderson R, Bremner W, Huhtaniemi I, Nieschlag E et al. A multi-centre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive. Hum Reprod 2006;21:285-294.
15. Büchter D, von Eckardstein S, von Eckardstein A, Kamischke A, Simoni M, Behre HM, Nieschlag E. Clinical trial of transdermal testosterone and oral levonorgestrel for male contraception. J Clin Endocrinol Metab 1999;84:1244-1249.
16. Bujan L, Mansat A, Pontonnier F, Mieusset R. Time series analysis of sperm concentration in fertile men in Toulouse, France between 1977 and 1992. BMJ 1996;312:471-472.
17. Castilla JA, Alvarez C, Aguilar J, González-Varea C, Gonzalvo MC, Marti{dotless}ńez L. Influence of analytical and biological variation on the clinical interpretation of seminal parameters. Hum Reprod 2006;21: 847-51.
18. Chan SYW, Tang LCH, Tang GWK, Ho PC, Wang C. Spermatozoal fertilizing capacity in polyzoospermia: a preliminary study. Andrologia 1986;18:208-213.
19. Check JH, Bollendorf A, Press M, Blue T. Standard sperm morphology as a predictor of male fertility potential. Arch Androl 1992;28:39-41.
20. Chia SE, Tay SK, Lim ST. What constitutes a normal seminal analysis? Semen parameters of 243 fertile men. Hum Reprod 1998;13:3394-3398.
21. Coetzee K, Kruger TF, Lombard CJ. Predictive value of normal sperm morphology: a structured literature review. Hum Reprod Update 1998; 4:73-82.
22. Cohn BA, Overstreet JW, Fogel RJ, Brazil CK, Baird DD, Cirillo PM. Epidemiologic studies of human semen quality: considerations for study design. Am J Epidemiol 2002;155:664-671.
23. Cooper TG, Yeung CH. Computer-aided evaluation of assessment of 'grade a' spermatozoa by experienced technicians. Fertil Steril 2006; 85:220-224.
24. Cooper TG, Jockenhoevel F, Nieschlag E. Variations in semen parameters from fathers. Hum Reprod 1991;6:859-866.
25. Cooper TG, Atkinson AD, Nieschlag E. Experience with external quality control in spermatology. Hum Reprod 1999;14:765-769.
26. Cooper TG, Björndahl L, Vreeburg J, Nieschlag E. Semen analysis and external quality control schemes for semen analysis need global standardization. Int J Androl 2002;25:306-311.
27. Dybkaer R, Solberg HE. Approved recommendation on the theory of reference values. Part 6. Presentation of observed values related to reference values. Clinica Chemica Acta 1987;170:S33-S42.
28. Egeland T, Haugen TB. [Nuts and bolts of percentiles]. Tidsskr Nor Laegeforen 2007;127:733-734. Norwegian.
29. Eustache F, Auger J, Cabrol D, Jouannet P. Are volunteers delivering semen samples in fertility studies a biased population? Hum Reprod 2004;19:2831-2837.
30. Fisch H, Goluboff ET, Olson JH, Feldshuh J, Broder SJ, Barad DH. Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality. Fertil Steril 1996;65:1009-1014.
31. Gao J, Gao ES, Yang Q, Walker M, Wu JQ, Zhou WJ, Wen SW. Semen quality in a residential, geographic and age representative sample of healthy Chinese men. Hum Reprod 2007;22:477-484.
32. Gao J, Gao ES, Walker M, Yang Q, Wu JQ, Zhu QX, Wen SW. Reference values of semen parameters for healthy Chinese men. Urol Int 2008; 81:256-262.
33. Garrett C, Liu DY, Clarke GN, Rushford DD, Baker HW. Automated semen analysis: zona pellucida preferred' sperm morphometry and straight-line velocity are related to pregnancy rate in subfertile couples. Hum Reprod 2003;18:1643-1649.
34. Glezerman M, Bernstein D, Zakut C, Misgav N, Insler V. Polyzoospermia: a definite pathologic entity. Fertil Steril 1982;68:605-608.
35. Gonzalo IT, Swerdloff RS, Nelson AL, Clevenger B, Garcia R, Berman N, Wang C. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. J Clin Endocrinol Metab 2002;87:3562-3572.
36. Gu YQ, Wang XH, Xu D, Peng L, Cheng LF, Huang MK, Huang ZJ, Zhang GY. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab 2003;88:562-568.
37. Gunalp S, Onculoglu C, Gurgan T, Kruger TF, Lombard CJ. A study of semen parameters with emphasis on sperm morphology in a fertile population: an attempt to develop clinical thresholds. Hum Reprod 2001;16:110-114.
38. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima S, Coutifaris C, Carson SA, Cisneros P, Steinkampf MP, Hill JA et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001;345:1388-1393.
39. Handelsman DJ. Estimating familial and genetic contributions to variability in human testicular function: a pilot twin study. Int J Androl 1997; 20:215-221.
40. Handelsman DJ. Optimal power transformations for analysis of sperm concentration and other semen variables. J Androl 2002; 23:629-634.
41. Handelsman DJ, Dunn SM, Conway AJ, Boylan LM, Jansen RP. Psychological and attitudinal profiles in donors for artificial insemination. Fertil Steril 1985;43:95-101.
42. Hansen AM, Christensen JM, Sherson D. Estimation of reference values for urinary 1-hydroxypyrene and alpha-naphthol in Danish workers. Sci Total Environ 1995;163:211-219.
43. Haugen TB, Egeland T, Magnus O. Semen parameters in Norwegian fertile men. J Androl 2006;27:66-71.
44. Hauser R, Godfrey-Bailey L, Chen Z. Does the potential for selection bias in semen quality studies depend on study design? Experience from a study conducted within an infertility clinic. Hum Reprod 2005; 20:2579-2583.
45. Hay CJ, Brady BM, Zitzmann M, Osmanagaoglu K, Pollanen P, Apter D, Wu FC, Anderson RA, Nieschlag E, Devroey P et al. A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception. J Clin Endocrinol Metab 2005; 90:2042-2049.
46. Hjollund NH, Jensen TK, Bonde JP, Henriksen TB, Andersson AM, Kolstad HA, Ernst E, Biwercman AJ, Skakkebaek NE, Olsen J. [Stress and fertility]. A follow-up study among couples planning the first pregnancy. Ugeskr Laeger 2000;162:5081-5086. Danish.
47. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chim Acta 2003; 334:5-23.
48. Irvine S, Cawood E, Richardson D, MacDonald E, Aitken J. Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 557 men in Scotland over 11 years. Br Med J 1996;312:467-471.
49. Iwamoto T, Nozawa S, Yoshiike M, Hoshino T, Baba K, Matsushita T, Tanaka SN, Naka M, Skakkebaek NE, Jørgensen N. Semen quality of 324 fertile Japanese men. Hum Reprod 2006;21:760-765.
50. Jensen TK, Slama R, Ducot B, Suominen J, Cawood EH, Andersen AG, Eustache F, Irvine S, Auger S, Jouannet P et al. Regional differences in waiting time to pregnancy among fertile couples from four European cities. Hum Reprod 2001;16:2697-2704.
51. Jensen TK, Carlsen E, Jørgensen N, Berthelsen JG, Keiding N, Christensen K, Petersen JH, Knudsen LB, Skakkebaek NE. Poor semen quality may contribute to recent decline in fertility rates. Hum Reprod 2002;17:1437-1440.
52. Joffe M. Time trends in biological fertility in Britain. Lancet 2000; 355:1961-1965.
53. Jonckheere K, Callewaert N, Grootenhuis AJ, Kersemaekers WM, Cooper TG. Feasibility study for the centralized measurement of sperm concentration. Int J Androl 2005;28:311-315.
54. Jørgensen N, Andersen AG, Eustache F, Irvine DS, Suominen J, Petersen JH, Andersen AN, Auger J, Cawood EH, Horte A et al. Regional differences in semen quality in Europe. Hum Reprod 2001; 16:1012-1019.
55. Jouannet P, Cyzglik F, David G, Mayaux MJ, Spira A, Moscato ML, Schwartz D. Study of a group of 484 fertile men. Part I: distribution of semen characteristics. Int J Androl 1981;4:440-449.
56. Jouannet P, Wang C, Eustache F, Kold-Jensen T, Auger J. Semen quality and male reproductive health: the controversy about human sperm concentration decline. APMIS 2001;109:333-344.
57. Junqing W, Qiuying Y, Jianguo T, Wei Y, Liwei B, Yuxian L, Yumei Z, Kangshou Y, Weiqun L, Lu C et al. Reference value of semen quality in Chinese young men. Contraception 2002;65:365-368.
58. Kamischke A, Diebäcker J, Nieschlag E. Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function. Clin Endocrinol 2000a;53:351-358.
59. Kamischke A, Plöger D, Venherm S, von Eckardstein S, von Eckardstein A, Nieschlag E. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception. (Erratum published in Clin Endocrinol 53 661). Clin Endocrinol 2000b;53:43-52.
60. Kamischke A, Simoni M, Schrameyer K, Lerchl A, Nieschlag E. Is inhibin B a pharmacodynamic parameter for FSH in normal men? Eur J Endocrinol 2001a;144:629-637.
61. Kamischke A, Venherm S, Plöger D, von Eckardstein S, Nieschlag E. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. J Clin Endocrinol Metab 2001b; 86:303-309.
62. Kamischke A, Heuermann T, Krüger K, von Eckardstein S, Schellschmidt I, Rübig A, Nieschlag E. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. J Clin Endocrinol Metab 2002;87:530-539.
63. Katz DF, Overstreet JW, Hanson FW. A new quantitative test for sperm penetration into cervical mucus. Fertil Steril 1980;33:179-186.
64. Koduah M, Iles TC, Nix BJ. Centile charts 1: new method of assessment for univariate reference intervals. Clin Chem 2004;50:901-906.
65. Larsen SB, Abell A, Bonde JP. Selection bias in occupational sperm studies. Am J Epidemiol 1998;147:681-685.
66. Lemcke B, Behre HM, Nieschlag E. Frequently subnormal semen profiles of normal volunteers recruited over 17 years. Int J Androl 1997; 20:144-152.
67. Leto S, Frensilli F. Changing parameters of donor semen. Fertil Steril 1981; 36:766-770.
68. MacLeod J. The male factor in fertility and infertility; an analysis of ejaculate volume in 800 fertile men and in 600 men in infertile marriage. Fertil Steril 1950;1:347-361.
69. MacLeod J. Semen quality in 1000 men of known fertility and in 800 cases of infertile marriage. Fertil Steril 1951;2:115-39.
70. MacLeod J, Gold RZ. The male factor in fertility and infertility. II. Spermatozoon counts in 1000 men of known fertility and in 1000 cases of infertile marriage. J Urol 1951a;66:439-449.
71. MacLeod J, Gold RZ. The male factor in fertility and infertility. III. An analysis of motile activity in the spermatozoa of 1000 fertile men and 1000 men in infertile marriage. Fertil Steril 1951b;2:187-204.
72. MacLeod J, Wang Y. Male fertility potential in terms of semen quality: a review of the past, a study of the present. Fertil Steril 1979;31: 103-116.
73. Macomber D, Sanders MD. The spermatozoa count: its value in the diagnosis, prognosis and concentration in fertile and infertile men. N Engl J Med 1929;200:981-984.
74. McLachlan RI, McDonald J, Rushford D, Robertson DM, Garrett C, Baker HW. Efficacy and acceptability of testosterone implants, alone or in combination with a 5α-reductase inhibitor, for male hormonal contraception. Contraception 2000;62:73-78.
75. McLachlan R I, O'Donnell L, Stanton PG, Balourdos G, Frydenberg M, de Kretser DM, Robertson DM. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men. J Clin Endocrinol Metab 2002;87:546-556.
76. Menkveld R, Wong WY, Lombard CJ, Wetzels AM, Thomas CM, Merkus HM, Steegers-Theunissen RP. Semen parameters, including WHO and strict criteria morphology, in a fertile and subfertile population: an effort towards standardization of in-vivo thresholds. Hum Reprod 2001;16:1165-1171.
77. Meriggiola MC, Bremner WJ, Paulsen CA, Valdiserri A, Incorvaia L, Motta R, Pavani A, Capelli M, Flamigni C. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive. J Clin Endocrinol Metab 1996;81:3018-3023.
78. Meriggiola MC, Costantino A, Cerpolini S, Bremner WJ, Huebler D, Morselli-Labate AM, Kirsch B, Bertaccini A, Pelusi C, Pelusi G. Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men. J Clin Endocrinol Metab 2003;88:5818-5826.
79. Meriggiola MC, Costantino A, Saad F, D'Emidio L, Labate AM, Bertaccini A, Bremner W, Rudolph I, Ernst M, Kirsch B et al. Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis and prostate. J Clin Endocrinol Metab 2005;90: 2005-2014.
80. Muller A, De La Rochebrochard E, Labbe-Decleves C, Jouannet P, Bujan L, Mieusset R, Le Lannou D, Guerin JF, Benchaib M, Slama R et al. Spira A. Selection bias in semen studies due to self-selection of volunteers. Hum Reprod 2004;19:2838-2844.
81. Murer AJ, Christensen JM, Midtgaard T. Determination of the urinary metabolites of styrene: estimation of the method evaluation function and evaluation of reference values in Danish subjects. Int Arch Occup Environ Health 1994;65:313-318.
82. Nallella KP, Sharma RK, Aziz N, Agarwal A. Significance of sperm characteristics in the evaluation of male infertility. Fertil Steril 2006; 85:629-634.
83. Ombelet W, Bosmans E, Janssen M, Cox A, Vlasselaer J, Gyselaers W, Vandeput H, Gielen J, Pollet H, Maes M et al. Semen parameters in a fertile versus subfertile population: a need for change in the interpretation of semen testing. Hum Reprod 1997;12:987-993.
84. Page EW, Houlding F. The clinical interpretation of 1000 semen analyses among applicants for sterility studies. Fertil Steril 1951; 2:140-151.
85. Pal PC, Rajalakshmi M, Manocha M, Sharma RS, Mittal S, Rao DN. Semen quality and sperm functional parameters in fertile Indian men. Andrologia 2006;38:20-25.
86. Pasqualotto FF, Sobreiro BP, Hallak J, Athayde KS, Pasqualotto EB, Lucon AM. High percentage of abnormal semen parameters in a prevasectomy population. Fertil Steril 2006;85:954-960.
87. Pater C. The blood pressure 'uncertainty range'-a pragmatic approach to overcome current diagnostic uncertainties (II). Curr Control Trials Cardiovasc Med 2005;6:5-21.
88. Paulsen CA, Berman NG, Wang C. Data from men in greater Seattle area reveals no downward trend in semen quality: further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 1996;65:1015-1020.
89. PetitClerc C, Solberg HE. Approved recommendations (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values. Clinica Chemica Acta 1987;170:S3-S12.
90. Qoubaitary A, Meriggiola C, Ng CM, Lumbreras L, Cerpolini S, Pelusi G, Christensen PD, Hull L, Swerdloff RS, Wang C. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men. J Androl 2006;27:853-867.
91. Rehan N, Sobrero AJ, Fertig JW. The semen of fertile men: statistical analysis of 1300 men. Fertil Steril 1975;26:492-502.
92. Rowe PJ, Comhaire FH, Hargreave TB, Mellows HJ. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press, 1993, 83 p.
93. Rowe PJ, Comhaire FH, Hargreave TB, Mahmoud AM. WHO Manual for the Standardized Investigation, Diagnosis and Management of the Infertile Male. Cambridge: Cambridge University Press, 2000, 91 p.
94. Schill W-B, Feifel M. Low acrosin activity in polyzoospermia. Andrologia 1984;16:589-591.
95. Slama R, Eustache F, Ducot B, Jensen TK, Jørgensen N, Horte A, Irvine S, Suominen J, Andersen AG, Auger J et al. Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod 2002;17:503-515.
96. Slama R, Kold-Jensen T, Scheike T, Ducot B, Spira A, Keiding N. How would a decline in sperm concentration over time influence the probability of pregnancy? Epidemiology 2004;15:458-465.
97. Solberg HE. International federation of clinical chemistry. scientific committee, clinical section. expert panel on theory of reference values and international committee for standardization in haematology standing committee on reference values. Approved recommendation (1986) on the theory of reference values. Part 1. The concept of references values. Clin Chim Acta 1987;165:111-118.
98. Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med 2004;42:710-714.
99. Solberg HE. Establishment and use of reference values. In: Burts CA, Ashwood ER, Bruns DE (eds). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Philadelphia: Elsevier Inc, 2006. 425-448.
100. Sultan Sheriff D. Setting standards of male fertility I. Semen analyses in 1500 patients-a report. Andrologia 1983;15:687-692.
101. Stewart TM, Liu DY, Garrett C, Jørgensen N, Brown EH, Baker HWG. Associations between andrological measures, hormones and semen quality in ferile Australian men: inverse relationship between obesity and sperm output. Hum Reprod 2009;24:1561-1568.
102. Swan SH. Do environmental agents affect semen quality? Epidemiology 2003;14:261-262.
103. Swan SH, Brazil C, Drobnis EZ, Liu F, Kruse RL, Hatch M, Redmon JB, Wang C, Overstreet JW. Geographic differences in semen quality of fertile U.S. males. Environ Health Perspect 2003;111:414-420.
104. te Velde ER, Eijkemans R, Habbema HD. Variation in couple fecundity and time to pregnancy, an essential concept in human reproduction. Lancet 2000;355:1928-1929.
105. Tielemans E, Burdorf A, te Velde E, Weber R, van Kooij R, Heederik D. Sources of bias in studies among infertility clients. Am J Epidemiol 2002;156:86-92.
106. Töpfer-Petersen E, Völcker C, Heissler E, Schill W-B. Absence of acrosome reaction in polyzoospermia. Andrologia 1987;19:225-228.
107. Tournaye H, Staessen C, Camus M, Verheyen G, Devroey P, Van Steirteghem A. No evidence for a decreased fertilizing potential after in-vitro fertilization using spermatozoa from polyzoospermic men. Hum Reprod 1997;12:2183-2185.
108. Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan R I, Handelsman DJ. Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 2003; 88:4659-4667.
109. van der Merwe FH, Kruger TF, Oehninger SC, Lombard CJ. The use of semen parameters to identify the subfertile male in the general population. Gynecol Obstet Invest 2005;59:86-91.
110. Van Waart J, Kruger TF, Lombard CJ, Ombelet W. Predictive value of normal sperm morphology in intrauterine insemination (IUI): a structured literature review. Hum Reprod Update 2001;7:495-500.
111. Van Waeleghem K, De Clercq N, Vermeulen L, Schoonjons F, Comhaire F. Deterioration of sperm quality in young healthy Belgian men. Hum Reprod 1996;11:325-329.
112. von Eckardstein S, Noe G, Brache V, Nieschlag E, Croxatto H, Alvarez F, Moo-Young A, Sivin I, Kumar N, Small M et al. International Committee for Contraception Research, The Population Council. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. J Clin Endocrinol Metab 2003; 88:5232-5239.
113. Walton MJ, Kumar N, Baird DT, Ludlow H, Anderson RA. 7α-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in normal men. J Androl 2007;28:679-688.
114. Wang C, Chan SY, Leung A, Ng RP, Ng M, Tang LC, Ma HK, Tsoi WL, Kwan M. Cross-sectional study of semen parameters in a large group of normal Chinese men. Int J Androl 1985;8:257-274.
115. Wang C, Wang XH, Nelson AL, Lee KK, Cui YG, Tong JS, Berman N, Lumbreras L, Leung A, Hull L et al. Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men. J Clin Endocrinol Metab 2006;91:460-470.
116. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-cervical Mucus Interaction, 2nd edn. Cambridge: Cambridge University Press, 1987, 80 p.
117. World Health Organization. Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990;336:955-959.
118. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-cervical Mucus Interaction, 3rd edn. Cambridge: Cambridge University Press, 1992, 107 p.
119. World Health Organization. Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996;65:821-829.
120. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-cervical Mucus Interaction, 4th edn. Cambridge: Cambridge University Press, 1999, 128 p.
121. Zinaman MJ, Brown CC, Selevan SG, Clegg ED. Semen quality and human fertility: a prospective study with healthy couples. J Androl 2000; 21:145-153.
122. Zukerman Z, Rodriguez-Rigau LJ, Smith KD, Steinberger E. Frequency distribution of sperm counts in fertile and infertile males. Fertil Steril 1977;28:1310-1313.